Skip to main content

Atopic Dermatitis Topic Center

Featured

Atopic dermatitis
News
02/18/2025
New monoclonal antibody offers targeted relief for patients with persistent itch and skin lesions
New monoclonal antibody offers targeted relief for patients with persistent itch and skin lesions
New monoclonal antibody offers...
02/18/2025
The Dermatologist
Atopic dermatitis
News
12/23/2024
A comprehensive study finds no significant link between exposure to tobacco smoke and the severity or activity of atopic dermatitis in children and adolescents.
A comprehensive study finds no significant link between exposure to tobacco smoke and the severity or activity of atopic dermatitis in children and adolescents.
A comprehensive study finds no...
12/23/2024
The Dermatologist
Atopic dermatitis
News
12/18/2024
A traditional remedy, white mulberry demonstrates therapeutic potential for eczema, offering a natural alternative to chemical treatments.
A traditional remedy, white mulberry demonstrates therapeutic potential for eczema, offering a natural alternative to chemical treatments.
A traditional remedy, white...
12/18/2024
The Dermatologist
Atopic dermatitis
FDA Alerts
12/16/2024
Organon’s VTAMA cream, 1%, offers a steroid-free solution for patients 2 years and older with moderate-to-severe atopic dermatitis, featuring powerful skin clearance and rapid itch relief.
Organon’s VTAMA cream, 1%, offers a steroid-free solution for patients 2 years and older with moderate-to-severe atopic dermatitis, featuring powerful skin clearance and rapid itch relief.
Organon’s VTAMA cream, 1%,...
12/16/2024
The Dermatologist
Atopic dermatitis
FDA Alerts
12/16/2024
Galderma’s Nemluvio (nemolizumab) offers a novel treatment targeting IL-31 receptor alpha, addressing itch and inflammation in atopic dermatitis.
Galderma’s Nemluvio (nemolizumab) offers a novel treatment targeting IL-31 receptor alpha, addressing itch and inflammation in atopic dermatitis.
Galderma’s Nemluvio...
12/16/2024
The Dermatologist
atopic dermatitis
FDA Alerts
09/16/2024
The US Food and Drug Administration has approved Eli Lilly’s EBGLYSS (lebrikizumab-lbkz), an IL-13 inhibitor, for the treatment of moderate to severe atopic dermatitis in adults and children.
The US Food and Drug Administration has approved Eli Lilly’s EBGLYSS (lebrikizumab-lbkz), an IL-13 inhibitor, for the treatment of moderate to severe atopic dermatitis in adults and children.
The US Food and Drug...
09/16/2024
The Dermatologist
Atopic dermatitis
FDA Alerts
07/09/2024
The US Food and Drug Administration has approved roflumilast cream 0.15% for the treatment of mild to moderate atopic dermatitis in adults and children aged 6 and older.
The US Food and Drug Administration has approved roflumilast cream 0.15% for the treatment of mild to moderate atopic dermatitis in adults and children aged 6 and older.
The US Food and Drug...
07/09/2024
The Dermatologist
psoriasis
News
06/24/2024
In a recent phase 2a clinical trial PF-07038124, a topical phosphodiesterase 4 inhibitor, has shown significant promise in treating both atopic dermatitis and plaque psoriasis, 2 common inflammatory skin conditions known for their challenging...
In a recent phase 2a clinical trial PF-07038124, a topical phosphodiesterase 4 inhibitor, has shown significant promise in treating both atopic dermatitis and plaque psoriasis, 2 common inflammatory skin conditions known for their challenging...
In a recent phase 2a clinical...
06/24/2024
The Dermatologist
eczema
News
06/22/2024
In a new approach to assess long-term treatment outcomes for atopic dermatitis (AD), researchers have introduced a novel efficacy index that accounts for both on-drug and off-drug responses at Week 52.
In a new approach to assess long-term treatment outcomes for atopic dermatitis (AD), researchers have introduced a novel efficacy index that accounts for both on-drug and off-drug responses at Week 52.
In a new approach to assess...
06/22/2024
The Dermatologist
Atopic dermatitis
News
06/21/2024
In recent findings from the ADvocate1 and ADvocate2 studies, lebrikizumab has shown promising results in treating moderate-to-severe atopic dermatitis.
In recent findings from the ADvocate1 and ADvocate2 studies, lebrikizumab has shown promising results in treating moderate-to-severe atopic dermatitis.
In recent findings from the...
06/21/2024
The Dermatologist
Atopic dermatitis
News
06/20/2024
Atopic dermatitis (AD) significantly impacts adults, with a meta-analysis showing that 26.1% of AD cases have an onset after age 16 years.
Atopic dermatitis (AD) significantly impacts adults, with a meta-analysis showing that 26.1% of AD cases have an onset after age 16 years.
Atopic dermatitis (AD)...
06/20/2024
The Dermatologist

Multimedia

Fall Clinical AD Roundtable
Videos
11/03/2022
​​​​​​In this video, Drs Swanson, Golant, Ungar, and Shahriari met to discuss the diagnosis, treatment, and management of atopic dermatitis.
​​​​​​In this video, Drs Swanson, Golant, Ungar, and Shahriari met to discuss the diagnosis, treatment, and management of atopic dermatitis.
​​​​​​In this video, Drs...
11/03/2022
The Dermatologist
Roundtable AAD
Videos
08/15/2022
In this video, live at the 2022 AAD Annual Meeting, Drs Paller, Friedman, Kwatra, and Blauvelt held a discussion atopic dermatitis following conference.
In this video, live at the 2022 AAD Annual Meeting, Drs Paller, Friedman, Kwatra, and Blauvelt held a discussion atopic dermatitis following conference.
In this video, live at the 2022...
08/15/2022
The Dermatologist
Drs Friedman, Lio, Shi and Kirkorian
Videos
07/15/2022
In this expert roundtable, Drs Friedman, Lio, Shi, and Kirkorian meet to discuss the diagnosis, treatment, and management of atopic dermatitis following the AAAAI 2022 meeting.
In this expert roundtable, Drs Friedman, Lio, Shi, and Kirkorian meet to discuss the diagnosis, treatment, and management of atopic dermatitis following the AAAAI 2022 meeting.
In this expert roundtable, Drs...
07/15/2022
The Dermatologist
Jeff Yu, MD
Videos
04/29/2022
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how...
04/29/2022
The Dermatologist
Shawn Kwatra, MD
Videos
04/13/2022
Prior to the 4th Annual Revolutionizing Atopic Dermatitis Conference (RAD), Dr Shawn Kwatra went over managing itch, the efficacy of current treatments, and more during this interview.
Prior to the 4th Annual Revolutionizing Atopic Dermatitis Conference (RAD), Dr Shawn Kwatra went over managing itch, the efficacy of current treatments, and more during this interview.
Prior to the 4th Annual...
04/13/2022
The Dermatologist
Patrick Burnett
Videos
03/13/2025
Dr Patrick Burnett discusses the significance of roflumilast cream, a non-steroidal treatment, its rapid itch relief within 24 hours, and its role in long-term disease management.
Dr Patrick Burnett discusses the significance of roflumilast cream, a non-steroidal treatment, its rapid itch relief within 24 hours, and its role in long-term disease management.
Dr Patrick Burnett discusses the...
03/13/2025
The Dermatologist
Fabrizio Galimberti, MD
Videos
03/13/2025
Generalized pustular psoriasis (GPP) is a rare but life-threatening condition that requires early recognition and prompt intervention.
Generalized pustular psoriasis (GPP) is a rare but life-threatening condition that requires early recognition and prompt intervention.
Generalized pustular psoriasis...
03/13/2025
The Dermatologist
Abigail H. Waldman, MD, FAAD
Videos
03/06/2025
Learn how dermatologists can optimize patient outcomes while integrating emerging data into daily practice.
Learn how dermatologists can optimize patient outcomes while integrating emerging data into daily practice.
Learn how dermatologists can...
03/06/2025
The Dermatologist
Dr Grant-Kels
Videos
03/06/2025
Learn practical approaches for improving diagnosis, leveraging dermoscopy, and enhancing patient education in high-risk groups.
Learn practical approaches for improving diagnosis, leveraging dermoscopy, and enhancing patient education in high-risk groups.
Learn practical approaches for...
03/06/2025
The Dermatologist
Adewole Shomari Adamson, MD, MPP, FAAD
Videos
03/06/2025
Gain practical insights on improving diagnostic accuracy, minimizing unnecessary interventions, and refining patient-centered strategies for melanoma screening in daily practice.
Gain practical insights on improving diagnostic accuracy, minimizing unnecessary interventions, and refining patient-centered strategies for melanoma screening in daily practice.
Gain practical insights on...
03/06/2025
The Dermatologist
Melissa Mauskar, MD
Videos
02/17/2025
In this video, Dr Mauskar delves into the impact of hormonal changes on women’s skin and hair health, particularly during puberty, pregnancy, perimenopause, and menopause, highlighting common dermatological concerns such as dryness, vulvar...
In this video, Dr Mauskar delves into the impact of hormonal changes on women’s skin and hair health, particularly during puberty, pregnancy, perimenopause, and menopause, highlighting common dermatological concerns such as dryness, vulvar...
In this video, Dr Mauskar delves...
02/17/2025
The Dermatologist

From the Issue

Jeff Yu, MD
Videos
04/29/2022
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how...
04/29/2022
The Dermatologist
Emma Guttman-Yassky, MD, PhD
Feature Story
10/10/2021
Recently presented clinical trial data on investigational drug candidate etrasimod, a novel investigational therapy, shows promise for treating moderate to severe atopic dermatitis.
Recently presented clinical trial data on investigational drug candidate etrasimod, a novel investigational therapy, shows promise for treating moderate to severe atopic dermatitis.
Recently presented clinical...
10/10/2021
The Dermatologist
Pop Quiz: Cardiovascular Risk and Atopic Dermatitis
NEA Approved Features
05/17/2021
What immune pathways are most implicated in the pathogenesis of atherosclerosis and AD, respectively?
What immune pathways are most implicated in the pathogenesis of atherosclerosis and AD, respectively?
What immune pathways are most...
05/17/2021
The Dermatologist
Quiz: Pain in Atopic Dermatitis
NEA Approved Features
03/12/2021
While itch is the most burdensome symptom of AD, pain can also cause stress and negatively affect quality of life.
While itch is the most burdensome symptom of AD, pain can also cause stress and negatively affect quality of life.
While itch is the most...
03/12/2021
The Dermatologist
Get Eczema Wise During Eczema Awareness Month
Partner Approved
10/16/2020
As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.
As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.
As research continues to better...
10/16/2020
The Dermatologist
Dupilumab Treatment Provides Multidimensional Improvement of Signs, Symptoms, and Quality of Life in Children With Severe Atopic Dermatitis: A Pictorial Guide
Feature Story
08/13/2020
This visual 12-patient series by Drs Shumel and Rossi demonstrates the efficacy of dupilumab in patients aged 6 to 11 years with severe atopic dermatitis treated over a 16-week period.
This visual 12-patient series by Drs Shumel and Rossi demonstrates the efficacy of dupilumab in patients aged 6 to 11 years with severe atopic dermatitis treated over a 16-week period.
This visual 12-patient series by...
08/13/2020
The Dermatologist
NEA Approved Features
03/06/2025
National Eczema Association survey examines the frequency of acute care needs among patients with atopic dermatitis and the wait times they experience when seeking care from their primary atopic dermatitis health care providers.
National Eczema Association survey examines the frequency of acute care needs among patients with atopic dermatitis and the wait times they experience when seeking care from their primary atopic dermatitis health care providers.
National Eczema Association...
03/06/2025
The Dermatologist
Feature Story
12/02/2024
Embracing a respectful approach to the aging process is essential for recognizing the rich tapestry of experiences that shape individuals over time.
Embracing a respectful approach to the aging process is essential for recognizing the rich tapestry of experiences that shape individuals over time.
Embracing a respectful approach...
12/02/2024
The Dermatologist
NEA Approved Features
12/02/2024
Aligning patient and health care provider definitions can improve communication, treatment effectiveness, and research strategies.
Aligning patient and health care provider definitions can improve communication, treatment effectiveness, and research strategies.
Aligning patient and health care...
12/02/2024
The Dermatologist
Feature Story
10/07/2024
The implementation of a dedicated shelf exam for dermatology can help standardize fourth-year rotations, leveling the playing field for students from less-prestigious medical schools and helping them demonstrate their enthusiasm for our...
The implementation of a dedicated shelf exam for dermatology can help standardize fourth-year rotations, leveling the playing field for students from less-prestigious medical schools and helping them demonstrate their enthusiasm for our...
The implementation of a...
10/07/2024
The Dermatologist
Feature Story
09/06/2024
This article discusses natural alternatives to conventional treatments and explains how many conventional dermatology treatments can be considered natural themselves.
This article discusses natural alternatives to conventional treatments and explains how many conventional dermatology treatments can be considered natural themselves.
This article discusses natural...
09/06/2024
The Dermatologist
NEA Approved Features
09/06/2024
We know that the mental health burden of having atopic dermatitis is real, but are patients getting the help they need?
We know that the mental health burden of having atopic dermatitis is real, but are patients getting the help they need?
We know that the mental health...
09/06/2024
The Dermatologist
Feature Story
08/05/2024
Have natural language processing and large language models matured enough to support implementation of artificial intelligence-assisted scribing in the right clinical setting?
Have natural language processing and large language models matured enough to support implementation of artificial intelligence-assisted scribing in the right clinical setting?
Have natural language processing...
08/05/2024
The Dermatologist
Business Insider
05/03/2024
In this era of rising inflation and decreasing reimbursement, dermatologists must seek creative ways to provide excellent care while ensuring that patients maintain access to our services.
In this era of rising inflation and decreasing reimbursement, dermatologists must seek creative ways to provide excellent care while ensuring that patients maintain access to our services.
In this era of rising inflation...
05/03/2024
The Dermatologist
NEA Approved Features
05/03/2024
When patients are aware of the connection between their mental health and their eczema symptoms, they may be more likely to seek support.
When patients are aware of the connection between their mental health and their eczema symptoms, they may be more likely to seek support.
When patients are aware of the...
05/03/2024
The Dermatologist
Feature Story
03/06/2024
Ross Lane Pearlman, MD
Innovations like machine learning models will change everything. But not in the most obvious ways.
Innovations like machine learning models will change everything. But not in the most obvious ways.
Innovations like machine...
03/06/2024
The Dermatologist